Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:LFCR

Lifecore Biomedical Q3 2026 Earnings Date & Estimates

Lifecore Biomedical logo
$6.44 +0.04 (+0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$6.43 -0.01 (-0.16%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lifecore Biomedical is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026. The conference call is scheduled for November 6, 2026 at 12:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Conference Call Date
Conference Call
12:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Lifecore Biomedical in Q3 2026

Lifecore Biomedical is expected to post earnings of -$0.2975 per share on revenue of $25.57 million. In the same quarter a year earlier Lifecore Biomedical reported -$0.29 per share on revenue of $31.11 million. Lifecore Biomedical last reported on August 5, 2026, posting -$0.19 per share and matching the -$0.19 consensus estimate. Lifecore Biomedical has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.2975
Expected Revenue
$25.57 million
Prior-Year EPS
-$0.29
Prior-Year Revenue
$31.11 million
Expected Revenue Growth
-17.8%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.19 (Met Expectations)
Last Quarter Revenue
$34.17 million
EPS Beat Rate
2 of last 8 quarters

Prepare for the Q3 2026 Call

Lifecore Biomedical Q3 2026 Earnings FAQ

Lifecore Biomedical (NASDAQ:LFCR) is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Lifecore Biomedical's Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Lifecore Biomedical to post earnings of -$0.2975 per share for Q3 2026.

The consensus revenue estimate for Lifecore Biomedical is $25.57 million for Q3 2026.

Lifecore Biomedical Earnings Headlines

Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
October 23 at 2:31 PM  |  insidermonkey.comhttps://www.insidermonkey.com/news/is-lifecore-biomedical-lfcr-an-asymmetric-risk-reward-in-pharma-contract-manufacturing-1858521/
Lifecore Sets Record Date for Merger Vote
October 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/lifecore-sets-record-date-for-merger-vote?utm_source=marketbeat.com&utm_medium=referral
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.tc pixel
October 26 at 1:00 AM  |  Crypto 101 Media (Ad)
Comparing Lifecore Biomedical (NASDAQ:LFCR) & Evolus (NASDAQ:EOLS)
October 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31133346
Financial Survey: Cumberland Pharmaceuticals (NASDAQ:CPIX) vs. Lifecore Biomedical (NASDAQ:LFCR)
October 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31128572
Lifecore Biomedical to Participate at Upcoming Industry Conferences
October 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/07/3376837/23089/en/lifecore-biomedical-to-participate-at-upcoming-industry-conferences.html
See More Lifecore Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email.

About Lifecore Biomedical

Lifecore Biomedical (NASDAQ:LFCR) is a contract development and manufacturing organization that provides development, formulation, aseptic filling, packaging and other manufacturing services for pharmaceutical and biopharmaceutical companies. The company specializes in complex sterile injectable products and supports customers from development through commercial production.

Lifecore has particular expertise in hyaluronic acid, a naturally occurring substance used in ophthalmic, orthopedic, aesthetic and other medical applications. Its capabilities also include manufacturing and filling other complex injectable and parenteral products, including products requiring specialized handling, high-viscosity processing or lyophilization.

Headquartered in Chaska, Minnesota, Lifecore serves customers in the United States and international markets. The business was historically associated with Landec Corporation, which acquired Lifecore in 1999; Landec changed its corporate name to Lifecore Biomedical in 2023 as part of a transition toward a healthcare-focused identity.

View Lifecore Biomedical Profile
Earnings Tools